Scrambling for BRAF Mutation Status in Patients With Melanoma: Is It Really Necessary to Initiate Treatment?

JCO Oncol Pract. 2022 Sep;18(9):679-680. doi: 10.1200/OP.22.00267. Epub 2022 Jun 27.

Authors

Muhammad Zain Farooq¹, Ankit Mangla¹

Affiliation

¹ Muhammad Zain Farooq, MD, Department of Hematology and Oncology, Moffitt Cancer Center, University of South Florida, Tampa, FL; and Ankit Mangla, MD, Seidman Cancer Center, University Hospitals, Cleveland, OH, Division of Hematology and Oncology, Case Western Reserve University School of Medicine, Cleveland, OH.

PMID: 35759736
DOI: 10.1200/OP.22.00267

No abstract available

Publication types

Letter
Comment

MeSH terms

Humans
Melanoma* / genetics
Melanoma* / therapy
Mutation
Proto-Oncogene Proteins B-raf* / genetics

Substances

BRAF protein, human
Proto-Oncogene Proteins B-raf